Browse views: by Year, by Function, by GLF, by Subfunction, by Conference, by Journal

Effect of ofatumumab on pregnancy, parturition, and lactation in cynomolgus monkeys.

Bellot, Muriel, Luetjens, C Marc, Bagger, Morten, Horvath, Courtney, Sutter, Esther, DeLise, Anthony, Brees, Dominique, Carballido, Jose, Pingili, Ratnakar, Ramanathan, Krishnan, Kieseier, Bernd and Hellwig, Kerstin (2021) Effect of ofatumumab on pregnancy, parturition, and lactation in cynomolgus monkeys. Reproductive toxicology (Elmsford, N.Y.), 108. pp. 28-34. ISSN 1873-1708

Abstract

Knowledge of the impacts of the anti-CD20 monoclonal antibody ofatumumab on the developing immune system is limited. This study examined the effects of intravenous ofatumumab on pregnancy, parturition, and lactation, and on pre- and postnatal survival and development in cynomolgus monkeys, an established model for developmental toxicity assessment. Pregnant cynomolgus monkeys (n = 42) were randomized to receive vehicle only (control group; n = 14), low-dose ofatumumab (n = 14), or high-dose ofatumumab (n = 14). Survival, clinical outcomes, and clinical pathology investigations were evaluated regularly until lactation day (maternal animals) and postnatal day 180±1 (infants). Anatomic pathology was investigated in euthanized infants and unscheduled terminations of maternal animals and infants. Ofatumumab treatment was not associated with maternal toxicity or embryotoxicity and had no effect on the growth and development of offspring. As expected, B-cell depletion occurred in maternal animals and their offspring, with a reduced humoral immune response in infants of mothers on high-dose ofatumumab. Both effects were reversible. In the high-dose group, perinatal deaths of 3 infants were attributed to infections, potentially secondary to pharmacologically induced immunosuppression. The no-observed adverse-effect level for initial/maintenance ofatumumab doses was 100/20 mg, and 10/3 mg/kg for pharmacological effects in infant animals, which are associated with exposures significantly higher than those following therapeutic doses in humans. In this study with cynomolgus monkeys, ofatumumab treatment was not associated with maternal toxicity or embryotoxicity and had no effect on the growth and development of offspring.

Item Type: Article
Date Deposited: 26 Apr 2022 00:45
Last Modified: 26 Apr 2022 00:45
URI: https://oak.novartis.com/id/eprint/45741

Search

Email Alerts

Register with OAK to receive email alerts for saved searches.